Since CHI3L1 plays a key role in the development of chronic inflammatory diseases and subsequent inflammation-mediated cellular carcinogenesis, therapeutic strategies that target CHI3L1 are a hotspot of current research and are expected to provide new avenues and approaches for tumor therapy. This evidence concerns the gene CHI3L1 and neoplasm.